Sonire Therapeutics

Sonics brings new future to cancer patients

Tokyo, United States · Founded 2020 · $18.0M raised

Headquarters
Tokyo, California
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$18.0M
Last Round
$18.0M Series AApr 2026
Rounds
1

About

Sonire Therapeutics is developing a next-generation high-intensity focused ultrasound (HIFU) treatment system for unresectable pancreatic cancer. The company uses acoustic engineering to target tumors non-invasively and has received breakthrough device designation in Japan. It is conducting a randomized Phase 2 study of its HIFU therapy system.

Summary

Sonire Therapeutics is a Healthcare company based in Tokyo, United States, founded in 2020. It has raised $18.0M in total across 1 round, most recently a $18.0M Series A round in Apr 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2026
$18.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sonire Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sonire-therapeutics"><img src="https://indexed.vc/api/badge/company/sonire-therapeutics" alt="Sonire Therapeutics on Indexed.vc" width="260" height="76" /></a>